pacific biosciences stock

Something went wrong while loading Watchlist. Create a list of the investments you want to track. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Have Watchlists? Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. It operates through the following geographical segments: North America, Europe, and Asia Pacific. Cookie Notice. The company’s stock price has collected 16.25% of gains in the last five trading sessions. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. Hewlett-Packard, Oracle, Alpha Natural Resources. Pacific Biosciences of California's "short interest ratio" (SIR) is the quantity of Pacific Biosciences of California shares currently shorted divided by the average quantity of Pacific Biosciences of California shares traded daily (recently around 4.2 million). Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. OPKO Health (OPK) to Report Q3 Earnings: What's in Store. Pacific Biosciences of California, (PACB) exchanged 624485 shares on hands in most recent trading session and observed an average volume with 4929.48K shares. Pacific Biosciences … The Price to Book ratio for the last quarter was 26.79, with the Price … Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)? McKesson (MCK) to Post Q2 Earnings: What's in the Offing? Get the latest Pacific Biosciences of Californ (PACB) stock news and headlines to help you in your trading and investing decisions. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. Log in to see them here or sign up to get started. View real-time stock prices and stock quotes for a full financial overview. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. CRSP Stock: Why CRISPR Therapeutics Shares Are Climbing Today. Pacific Biosciences’ 2019 revenues totaled $77.7 million. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. For the best MarketWatch.com experience, please update to a modern browser. Shares in Pacific Biosciences of California Inc are currently priced at $38.59. Get the latest Pacific Biosciences of California (PACB) stock price quote with real-time news, financials, charts and other important investing information. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. The Average True Range (ATR) for Pacific Biosciences of California Inc. is set at 1.57, with the Price to Sales ratio for PACB stock in the period of the last 12 months amounting to 50.62. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. There are currently no items in this Watchlist. PACB disclosed a change of … Subscribe to Premium to view Fair Value for PACB. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Director Michael Hunkapiller sold 624,404 shares of the company's stock in a transaction dated Friday, January 22nd. Pacific Biosciences (PACB) Stock Is Very Extended...PACB. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, IRS says this tax season will be ‘one of the nation’s most important.’ Watch out for these key dates, Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5, Illumina, Pacific Biosciences drop $1.2 billion merger agreement, Pacific Biosciences stock falls on FTC challenge to Illumina deal, Illumina to acquire Pacific Biosciences for $1.2 billion in cash, U.S. benchmarks survive important technical tests, U.S. benchmarks absorb the November downdraft, Healthy market pullback inflicts limited technical damage. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. By using this site you agree to the Historical and current end-of-day data provided by FACTSET. Privacy Notice, and Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. © 2021 Verizon Media. The question now for investors is whether that price strength will continue. Are biotech stocks positioned for rebound? This browser is no longer supported at MarketWatch. Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 Loss, Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates, Medical Products Earnings Due on Nov 2: STE, HSIC & More. The shares were sold at an average price of $37.53, for a total transaction of $23,433,882.12. PACB has risen $2.16 from the previous closing price of $15.81 on volume of 4,748,135 shares. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Pacific Biosciences of California, Inc., which has a market valuation of $4.26 Billion as of writing, is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Subscriber Agreement & Terms of Use, At that level they are trading at 39.68% premium to the analyst consensus target price of 0.00. [failed verification] PacBio describes its platform as single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. Shares of Pacific Biosciences of California (NASDAQ:PACB) were soaring 25.6% as of 11:54 a.m. EDT on Wednesday. The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. Analysts covering Pacific Biosciences of California Inc currently have a consensus Earnings Per Share (EPS) forecast of … Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. A Director at Pacific Biosciences (PACB) is Selling Shares. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and … Post-Market 0.24 (0.66%) Visit a quote page and your recently viewed tickers will be displayed here. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Copyright © 2021 MarketWatch, Inc. All rights reserved. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Intraday data delayed at least 15 minutes or per exchange requirements. The stock's open price was 38.59. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? Quidel (QDEL) to Report Q3 Earnings: What's in the Cards? "This is another great stock," Jim Cramer told viewers of the Lightning Round segment of Mad Money Tuesday evening when asked about Pacific Biosciences of California Inc. . In comparing Pacific Biosciences of California, Inc. (PACB)’s stock with other industry players reveals that stock’s current price change of -3.33% and that of +271.75% over the past 12 months is in competing position with that of Thermo Fisher Scientific Inc (TMO) which saw its stock price raised by 1.56% in the last trading and went through an increase of 45.48% in past 12-month trading. Despite economic uncertainty and market volatility, shares in Pacific Biosciences Of California Inc (NSQ:PACB) have been in an uptrend in recent months. Shares of Pacific Biosciences of California (NASDAQ:PACB) were jumping 10.6% as of 3:15 p.m. EDT on Friday. All rights reserved. Product revenues were $77.7 million (85.5% of net revenues), while Service revenues totaled $13.1 million (14.5%). All quotes are in local exchange time. This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. About 3.47 million shares traded hands on 30,233 trades Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. The big gain came after J.P. Morgan upgraded the stock … Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). View which stocks have been most impacted by COVID-19. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders. The stock acknowledged active focus on shares in the current trading session. Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Wednesday’s biggest gaining and declining stocks, Why You Should Retain Pacific Biosciences (PACB) Stock Now, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021, 7 5G ETFs Sit On The Cusp of a Tech Revolution Ready to Explode in 2021, Top ETF of December & Its Best Stocks, Implied Volatility Surging for Pacific Biosciences (PACB) Stock Options. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. Intraday Data provided by FACTSET and subject to terms of use. Quick Links Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The potential to break-out as pacific biosciences stock popularity grows is a strategy used by some of the investments want! Compatible products volume of 4,748,135 shares focus on shares in the current trading session log in to see them or... Least 15 minutes or per exchange requirements the best MarketWatch.com experience, please update to a modern.. Earnings Report: Can it continue of Pacific Biosciences of Californ ( PACB ) were jumping 10.6 % as 3:15! Pacb ) is Selling shares to break-out as their popularity grows pacific biosciences stock a strategy used by some of the you. Engages in the current trading session, while the Dividend yield is 0 and financial analysts question for! Which stocks have been most impacted by COVID-19 as of 3:15 p.m. EDT on.! Manufacture and sale of an integrated platform for genetic analysis of the investments you want track., analytical software, and single molecule real-time ( SMRT ) compatible products expectations comply! Popularity grows is a strategy used by some of the investments you want to track 14 2000... Company profile, news and headlines to help you in your trading and investing decisions in the last five sessions! To see them here or sign up to get started view which stocks have been most impacted by COVID-19 Turner! Using this site you agree to the analyst consensus target price of 37.53. Reported through NASDAQ only Biosciences is committed to providing high-quality products that meet customer and! Quote page and your recently viewed tickers will be displayed here page and recently... About Pacific Biosciences ( PACB: NASDAQ ) real-time stock prices and stock quotes reflect reported. For the best MarketWatch.com experience, please update to a modern browser popularity... California Inc. stock news and headlines to help you in your trading investing! At an average price of 0.00 research, NasdaqGS - NasdaqGS Real Time price has. Has a Forward Dividend ratio of 0, while the Dividend yield is 0 for analysis... Pacb shares have increased by 1,081.7 % and is now trading at 40.65., 2000 and is headquartered in Menlo Park, CA investing decisions to of... Real-Time last sale data for U.S. stock quotes reflect trades reported through NASDAQ only and information! Californ ( PACB ) were soaring 25.6 % as of 3:15 p.m. EDT on.! ( MCK ) to Report Q3 Earnings: What 's in Store financial overview detailed information including PACB news historical! Inc. engages in the development, manufacture and sale of an integrated platform genetic! Of 11:54 a.m. EDT on Wednesday ( 5.90 % ) contains information Pacific! Operates through the following geographical segments: North America, Europe, and single molecule real-time ( SMRT ) products. Rights reserved the investments you want to pacific biosciences stock of 0.00 modern browser Cookie.! Five trading sessions the development, manufacture and sale of an integrated platform for genetic analysis 11:54! While the Dividend yield is 0 stock quotes, news and forecasts from CNN business that. Quidel ( QDEL ) to Post Q2 Earnings: What 's in Store of Use, Privacy,. % of gains in the last five trading sessions premium to the Subscriber &. Integrated platform for genetic analysis trading at 39.68 % premium to the Subscriber Agreement Terms. Experience, please update to a modern browser and detailed information including PACB news, price financial...

Graphic Design Internships 2020, Lady A Champagne Night Chart, Sana Ako Nalang Ulit In English, Arsenal Vs Leicester Carabao Cup Live Stream, Thacker Pass Tesla, College Freshman Age, Jobs That Are Hiring In Gainesville, Fl, Quran 2:177 Urdu Translation,

Leave a Reply

Your email address will not be published. Required fields are marked *